Cimeio Therapeutics
PrivateLast Round
Series A
Apr 13, 2022
Total Funding Raised
$50M
Company Overview
Cimeio Therapeutics operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Series A round in April 2022.
Cimeio Therapeutics is a biotechnology company that develops Shielded-Cell & Immunotherapy Pairs (SCIP) to treat hematologic malignancies, autoimmune disorders, and genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cimeio Therapeutics Comparables
Compare Cimeio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vor Biopharma | 78% | |
| Beam Therapeutics | 68% | |
| Caribou Biosciences | 63% |
For institutional investors. Book with your work email.
Cimeio Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Cimeio Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Versant Ventures | Series A |
| BaseLaunch | Series A |
| University of Basel | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors grew 246% MoM to 2.3K.
For institutional investors. Book with your work email.
Cimeio Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cimeio Therapeutics's valuation, stock price, and market status.
Is Cimeio Therapeutics a public or private company?
Cimeio Therapeutics is a private company.
What is the current stock price of Cimeio Therapeutics?
Cimeio Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cimeio Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cimeio Therapeutics worth (valuation)?
Valuation information for Cimeio Therapeutics is not publicly available.
Can I buy Cimeio Therapeutics stock?
Cimeio Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cimeio Therapeutics's last funding round?
Cimeio Therapeutics's most recent funding round was Series A on April 13, 2022.
Who are the main investors in Cimeio Therapeutics?
Key investors in Cimeio Therapeutics include Versant Ventures.
Will Cimeio Therapeutics IPO soon?
No public IPO plans have been announced for Cimeio Therapeutics.
How can I track Cimeio Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cimeio Therapeutics's shares on secondary markets.